Sarepta Therapeutics (SRPT) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.61% |
| Dec 31, 2025 | 12.63% |
| Sep 30, 2025 | 15.89% |
| Jun 30, 2025 | 19.38% |
| Mar 31, 2025 | 21.30% |
| Dec 31, 2024 | 21.30% |
| Sep 30, 2024 | 20.67% |
| Jun 30, 2024 | 18.70% |
| Mar 31, 2024 | 18.59% |
| Dec 31, 2023 | 18.55% |
| Sep 30, 2023 | 22.55% |
| Jun 30, 2023 | 26.80% |
| Mar 31, 2023 | 27.66% |
| Dec 31, 2022 | 33.07% |
| Sep 30, 2022 | 36.02% |
| Jun 30, 2022 | 36.00% |
| Mar 31, 2022 | 37.27% |
| Dec 31, 2021 | 38.29% |
| Sep 30, 2021 | 41.10% |
| Jun 30, 2021 | 41.25% |
| Mar 31, 2021 | 40.59% |
| Dec 31, 2020 | 38.52% |
| Sep 30, 2020 | 35.66% |
| Jun 30, 2020 | 32.75% |
| Mar 31, 2020 | 29.46% |
| Dec 31, 2019 | 27.48% |
| Sep 30, 2019 | 26.31% |
| Jun 30, 2019 | 42.19% |
| Mar 31, 2019 | 39.48% |
| Dec 31, 2018 | 45.17% |
| Sep 30, 2018 | 56.28% |
| Jun 30, 2018 | 76.55% |
| Mar 31, 2018 | 77.18% |
| Dec 31, 2017 | 66.26% |
| Mar 31, 2017 | 56.40% |
| Dec 31, 2016 | 54.71% |
| Sep 30, 2016 | 70.88% |
| Jun 30, 2016 | 72.56% |
| Dec 31, 2015 | 78.34% |